针对家族性地中海热病的预防性胆固醇:对应答率进行了修订
A Wiener1,2, Y Shinar1,3, E Pras3,4
1The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Ramat Gan, Israel.
Scandinavian journal of rheumatology
|June 5, 2025
概括
患有M694V基因型的家族地中海热病 (FMF) 患者对菌素治疗的反应不足. 这凸显了改善疾病管理策略的必要性,以提高患者的生活质量.
科学领域:
- 遗传学 是一个遗传学.
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 家庭地中海热 (FMF) 是一种遗传性自身炎症性疾病,其特征是发烧和炎症的反复发作.
- 胆固醇是FMF的主要治疗方法,但患者之间的反应率有很大差异.
- MEFV基因是FMF的主要遗传决定因素,特定突变影响疾病严重程度和治疗反应.
研究的目的:
- 根据MEFV基因基因型,重新评估家族地中海热病 (FMF) 患者的素反应率.
- 评估M694V基因型对菌素疗效的影响.
- 根据FMF新兴疗法,为治疗策略提供信息.
主要方法:
- 从106名连续的FMF患者的医疗记录进行了回顾性分析.
- 根据每年的发作频率,将患者分为四个响应组:完全,几乎完全,相当控制和控制不良.
- 对MEFV基因突变的基因定型,重点是M694V同胞菌.
主要成果:
- 只有34%的M694V同胞菌实现了充分的疾病控制 (0-2次发作/年),而其他基因型的66% (p < 0.002).
- 42%的M694V同胞菌经历了不良的疾病控制 (>6次发作/年),而其他基因型的13% (p < 0.001).
- 具有足够控制的患者接受了较低的胆固醇剂量,没有患者患有粉样性粉症.
结论:
- 很大一部分 FMF 患者对菌素反应不充分,特别是那些具有 M694V 基因型的患者.
- 优化疾病控制和生活质量仍然是FMF患者的关键挑战.
- 这些发现强调了需要个性化治疗方法和开发替代治疗方法的需要.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
495
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
495
01:29Drugs for Treatment of Ulcerative Colitis in IBD
463
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
463
01:17Pericarditis III: Medical Management
316
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
316
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
439
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
439
01:21Rheumatic Heart Disease III: Medical Management
290
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
290
01:29Inflammatory Bowel Disease IV: Pharmacological Management
531
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
531